Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Leandro

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Acta Reumatologica Portuguesa|November 25, 2011
Biologic therapy and pregnancy. A systematic literature reviewM Bogas, M J Leandro
Scandinavian Journal of Rheumatology|October 2, 2001
Rheumatic diseases and malignancy--is there an association?M J Leandro, D A Isenberg
Clinical and Experimental Immunology|July 17, 2009
Translational Mini-Review Series on B Cell-Directed Therapies: The pathogenic role of B cells in autoantibody-associated autoimmune diseases--lessons from B cell-depletion therapyM J Leandro, I de la Torre
Best Practice & Research. Clinical Rheumatology|September 19, 2006
B cell depletion therapy in rheumatic diseaseJ C W Edwards, G Cambridge, M J Leandro
Rheumatology (Oxford, England)|July 12, 2007
Repeated B-cell depletion in clinical practiceJ C W Edwards, G Cambridge, M J Leandro
Rheumatic Diseases Clinics of North America|June 3, 2004
B lymphocyte depletion therapy with rituximab in rheumatoid arthritisJ C W Edwards, M J Leandro, G Cambridge
Annals of the Rheumatic Diseases|September 14, 2002
Clinical outcome in 22 patients with rheumatoid arthritis treated with B lymphocyte depletionM J Leandro, J C W Edwards, G Cambridge
Biochemical Society Transactions|August 28, 2002
B-lymphocyte depletion therapy in rheumatoid arthritis and other autoimmune disordersJ C W Edwards, M J Leandro, G Cambridge
Clinical and Experimental Immunology|August 12, 2017
B cell phenotypes in patients with rheumatoid arthritis relapsing after rituximab: expression of B cell-activating factor-binding receptors on B cell subsetsE Becerra, I De La Torre, M J Leandro, et al.
Rheumatology (Oxford, England)|December 26, 2006
Repeated B lymphocyte depletion with rituximab in rheumatoid arthritis over 7 yrsC Popa, M J Leandro, G Cambridge, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Acta Reumatologica Portuguesa|November 25, 2011
Biologic therapy and pregnancy. A systematic literature reviewM Bogas, M J Leandro
Scandinavian Journal of Rheumatology|October 2, 2001
Rheumatic diseases and malignancy--is there an association?M J Leandro, D A Isenberg
Clinical and Experimental Immunology|July 17, 2009
Translational Mini-Review Series on B Cell-Directed Therapies: The pathogenic role of B cells in autoantibody-associated autoimmune diseases--lessons from B cell-depletion therapyM J Leandro, I de la Torre
Best Practice & Research. Clinical Rheumatology|September 19, 2006
B cell depletion therapy in rheumatic diseaseJ C W Edwards, G Cambridge, M J Leandro
Rheumatology (Oxford, England)|July 12, 2007
Repeated B-cell depletion in clinical practiceJ C W Edwards, G Cambridge, M J Leandro
Rheumatic Diseases Clinics of North America|June 3, 2004
B lymphocyte depletion therapy with rituximab in rheumatoid arthritisJ C W Edwards, M J Leandro, G Cambridge
Annals of the Rheumatic Diseases|September 14, 2002
Clinical outcome in 22 patients with rheumatoid arthritis treated with B lymphocyte depletionM J Leandro, J C W Edwards, G Cambridge
Biochemical Society Transactions|August 28, 2002
B-lymphocyte depletion therapy in rheumatoid arthritis and other autoimmune disordersJ C W Edwards, M J Leandro, G Cambridge
Clinical and Experimental Immunology|August 12, 2017
B cell phenotypes in patients with rheumatoid arthritis relapsing after rituximab: expression of B cell-activating factor-binding receptors on B cell subsetsE Becerra, I De La Torre, M J Leandro, et al.
Rheumatology (Oxford, England)|December 26, 2006
Repeated B lymphocyte depletion with rituximab in rheumatoid arthritis over 7 yrsC Popa, M J Leandro, G Cambridge, et al.
Pageof 3